Zobrazeno 1 - 10
of 241
pro vyhledávání: ''
Autor:
Yan Yuan, Zhifan Zeng, Rong-Zhen Li, Weiwei Xiao, Hui Chang, Qiaoxuan Wang, Yuanhong Gao, Wei-Hao Xie
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 117-127 (2022)
Cancer Medicine
Cancer Medicine
Background Anal squamous cell carcinoma (ASCC) is a rare malignant tumor with increasing incidence. The goal of our study was to analyze the treatment outcome and prognostic factors of ASCC in South China in the past half‐century. Methods This stud
Autor:
Gyungyub Gong, Min Jeong Song, Kyung-Ja Cho, Ji-Seon Jeong, Yong Mee Cho, Uiree Jo, Joon Seon Song
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8899-8908 (2021)
Cancer Medicine
Cancer Medicine
Introduction A pericardial effusion (PE) has a variable etiology and the primary role is diagnosis of metastatic malignancy. We analyzed the PE cytology in a large cohort in accordance with the international system for reporting serous fluid cytopath
Autor:
Wenqi Jiang, Li-Qin Ping, Qingqing Cai, Bing Bai, Xiaoxiao Wang, Jibin Li, Qixiang Rong, Jia-Ying Mao, Yan-Xia He, Haixia He, Cheng Huang, Yan Gao, Zhi Ming Li, He Huang, Huiqiang Huang
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 21, Pp 7650-7664 (2021)
Cancer Medicine, Vol 10, Iss 21, Pp 7650-7664 (2021)
Purpose Some studies have indicated that using 500 mg/m2 rituximab combined with CHOP‐14 may be beneficial for elderly men but not women with diffuse large B‐cell lymphoma (DLBCL). The purpose of this study was to investigate the potential benefi
Autor:
Cheng Zhang, Qi Ling, Shusen Zheng, Jingqi Sun, Shi Feng, Haitao Huang, Tao Rui, Zhenhua Tu, X. Zhang
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6227-6238 (2021)
Cancer Medicine
Cancer Medicine
Background Sarcomatoid hepatocellular carcinoma (HCC) is a rare and highly lethal histological subtype of HCC, with completely unknown genetic etiology and therapeutic targets. Methods We included 16 patients with sarcomatoid HCC receiving radical re
Autor:
Shinichiro Takahashi, Motokazu Sugimoto, Takayuki Yoshino, Shogo Nomura, Masashi Kudo, Masaru Konishi, Hiroya Taniguchi, Naoto Gotohda, Motohiro Kojima, Shin Kobayashi
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 20, Pp 6998-7011 (2021)
Cancer Medicine, Vol 10, Iss 20, Pp 6998-7011 (2021)
Despite reports on poor survival outcomes after hepatectomy for colorectal liver metastases (CRLM) with BRAF V600E mutation (mBRAF) exist, the role of mBRAF testing for technically resectable cases remains unclear. A single‐center retrospective stu
Autor:
Arjun Sahgal, Umberto Ricardi, Hanbo Chen, Matthew Foote, Tithi Biswas, Kristin J. Redmond, Roi Dagan, Xuguang Chen, Darby Erler, Alexander V. Louie, Serena Badellino, Ian Poon
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6189-6198 (2021)
Cancer Medicine
Cancer Medicine
Background Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain. Methods An international database of patients with OMD treated wi
Autor:
Stéphane Oudard, Brigitte Laguerre, Carole Helissey, Mathilde Cancel, Diego Teyssonneau, Pierre Emmanuel Brachet, Edouard Auclin, Constance Thibault, Philippe Barthélémy, Johanna Noel, Cedric Pobel, Denis Maillet, Elouen Boughalem
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6304-6309 (2021)
Cancer Medicine
Cancer Medicine
Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it.
Autor:
Despina Kontos, Emily F. Conant, Katrina Armstrong, Sarah Ehsan, Constance D. Lehman, Alan Semine, Tara M. Friebel-Klingner, Kevin S. Hughes, Aditya Bardia, Susan M. Domchek, Wei He, Jinbo Chen, Michaela Welch, Anne Marie McCarthy
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 18, Pp 6456-6467 (2021)
Cancer Medicine, Vol 10, Iss 18, Pp 6456-6467 (2021)
Background Breast cancer is a heterogeneous disease, divided into subtypes based on the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Subtypes have different biology and prognos
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5545-5556 (2021)
Cancer Medicine
Cancer Medicine
Epigenetic regulation is important for cancer tumor metastasis and progression, including lung and liver cancer. However, the mechanism of epigenetic regulation in liver cancer leaves much to be discussed. According to a previous study, p300/CBP‐as
Autor:
Daneng Li, Nicolas Sommer, Wendy Verret, Riad Salem, Riccardo Lencioni, Sairy Hernandez, Beiying Ding
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5437-5447 (2021)
Cancer Medicine
Cancer Medicine
Background IMbrave150 is a phase III trial that assessed atezolizumab + bevacizumab (ATEZO/BEV) versus sorafenib (SOR) in patients with unresectable hepatocellular carcinoma (HCC) and demonstrated a significant improvement in clinical outcomes. Explo